Mapping body fat distribution: a key step towards the identification of the vulnerable patient? (Q37965730)

26 August 2017

Mapping body fat distribution: a key step towards the identification of the vulnerable patient? (English)

1 reference

26 August 2017

1 reference

3

Jean-Pierre Després

1 reference

26 August 2017

Benoit J Arsenault

1

1 reference

26 August 2017

Emilie Pelletier Beaumont

series ordinal

2

1 reference

26 August 2017

Eric Larose

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

12 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

44

1 reference

26 August 2017

8

1 reference

26 August 2017

758-772

1 reference

Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Ectopic fat accumulation and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Comparison of visceral adipose tissue mass in adult African Americans and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Familial clustering of abdominal visceral fat and total fat mass: the Québec Family Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Dietary determinants of changes in waist circumference adjusted for body mass index - a proxy measure of visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Human fat cell lipolysis: biochemistry, regulation and clinical role

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Role of body fat distribution and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

New imaging techniques of fat, muscle and liver within the context of determining insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

A prospective study of abdominal obesity and coronary artery calcium progression in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal subcutaneous adipose tissue: a protective fat depot?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Fatty acid metabolism in adipose tissue, muscle and liver in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The pathogenesis of atherosclerosis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The multiple facets of the fat tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Lipid accumulation in non-adipose tissue and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral fat and liver fat are independent predictors of metabolic risk factors in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Liver fat is not a marker of metabolic risk in lean premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Adiposity of the heart, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Epicardial fat: properties, function and relationship to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Aerobic exercise training reduces epicardial fat in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Weight loss in obesity reduces epicardial fat thickness; so what?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral fat in hypertension: influence on insulin resistance and beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Human epicardial adipose tissue is a source of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Longitudinal study of muscle strength, quality, and adipose tissue infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Pancreatic steatosis in humans: cause or marker of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

GHb level and subsequent mortality among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Long-term complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The pathologic continuum of diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Obesity and diabetes in the developing world--a growing challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

A potential decline in life expectancy in the United States in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Racial differences in abdominal depot–specific adiposity in white and African American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral Fat Is an Independent Predictor of All-cause Mortality in Men*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Abdominal Obesity Is an Independent Risk Factor for Chronic Heart Failure in Older People

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Myocardial Triglyceride Content and Epicardial Fat Mass in Human Obesity: Relationship to Left Ventricular Function and Serum Free Fatty Acid Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.605387

10.3109/07853890.2011.605387

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference